OAM
AMED

Origin Asset Management’s Amedisys AMED Stock Holding History

Origin Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,306
Closed -$218K – 93
2019
Q4 		$218K Buy
+1,306
New +$194K 0.02% 87
2019
Q2 		– Sell
-4,006
Closed -$494K – 86
2019
Q1 		$494K Hold
4,006
– – 0.04% 86
2018
Q4 		$469K Sell
4,006
-500
-11% -$58.9K 0.04% 91
2018
Q3 		$563K Hold
4,506
– – 0.04% 96
2018
Q2 		$385K Buy
+4,506
New +$331K 0.03% 103

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Origin Asset Management's AMED Position: Q1 2020 in Review

Origin Asset Management sold out of Amedisys (AMED) in Q1 2020, closing a stake of 1,306 shares — an estimated $218K sold.

Origin Asset Management first reported a position in AMED in Q2 2018 and held it in 5 quarters. The position peaked at $563K in Q3 2018. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Origin Asset Management reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • Origin Asset Management sold 1,306 Amedisys shares in Q1 2020, an estimated $218K.
  • Origin Asset Management first reported a position in Amedisys in Q2 2018 and held it in 5 quarters.
  • Origin Asset Management's Amedisys position peaked at $563K in Q3 2018.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Origin Asset Management's 13F filing for Q1 2020, filed 5 May 2020.